This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Mcgill University. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Jerry Pelletier: Innovator in Chemotherapeutic Agents
Introduction
Jerry Pelletier is a notable inventor based in Baie d'Urfé, Canada. He has made significant contributions to the field of biochemistry, particularly in the development of chemotherapeutic agents. His work focuses on innovative approaches to inhibit protein translation, which is crucial in cancer treatment.
Latest Patents
Jerry Pelletier holds a patent for "Chemotherapeutic agents for inhibition of protein translation." This invention relates to an anti-proliferative target for designing chemotherapeutic agents, which comprises an EIF4A protein having a specific amino acid sequence. This patent represents a significant advancement in the search for effective cancer therapies.
Career Highlights
Throughout his career, Jerry has worked with prestigious institutions such as McGill University and Cold Spring Harbor Laboratory. His experience in these renowned organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of Jerry's notable coworkers include Marie-Ève Bordeleau and Junichi Tanaka. Their collaborative efforts have furthered the understanding of protein translation and its implications in cancer treatment.
Conclusion
In summary, Jerry Pelletier is a distinguished inventor whose work in chemotherapeutic agents has the potential to impact cancer treatment significantly. His innovative approaches and collaborations with esteemed institutions highlight his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile